Decentralized clinical trials (DCTs) gained substantial global attention during the COVID-19 pandemic, enabling trial activities to continue directly from participants’ homes or local healthcare facilities despite severe restrictions and lockdowns. By removing the strict requirement for patients to travel to specialized academic medical centers, this model demonstrated immense potential to democratize clinical research. However, despite […]
